| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, CEO | Director
2 companies
Huber Martin H. Jr. is a Director at Syndax Pharmaceuticals Inc with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 3 sells.
Estimated insider holdings value: $1.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2025 | President, CEO | Sale+OE | 2,012 | $7.31 | $14,707.72 | -17.4% | - | - | ||
| May 19, 2025 | SNDX Syndax Pharmaceuticals Inc | Director | Buy | 5,000 | $8.99 | $44,950.00 | +6.8% | +70.6% | - | |
| Jan 16, 2025 | President, CEO | Sale+OE | 4,514 | $0.58 | $2,618.12 | -3.5% | - | - | ||
| Sep 12, 2024 | President, CEO | Sale+OE | 50,423 | $1.76 | $88,744.48 | -30.2% | - | - |